Ekso Bionics Holdings designs, develops, and markets exoskeleton products that improve human strength, endurance and mobility. Co.'s business units are EksoHealth and EksoWorks. Co.'s products in EksoHealth include: EksoNR, which is a robotic exoskeleton used to provide physical therapy for patients with lower extremity impairment; and EksoUE, which is a wearable upper body exoskeleton that is used as a tool during rehabilitation. Co.'s products in EksoWorks include: EksoVest and the EVO, both of which support the weight of a worker's arms and tools, reducing the fatigue associated with working; and EksoZeroG, which is a tool holder that can mount on an aerial lift platform or scaffolding. The EKSO stock yearly return is shown above.
The yearly return on the EKSO stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2022 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the EKSO annual return calculation with any dividends reinvested as applicable (on ex-dates).
|